Delivery Order SPE2DR25D1053-SPE2DR26FV834
- Not listed
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose 30-count packages. This order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30 count). This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of January 22, 2026. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, valued at $14,592.57 for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of February 6, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for supply of Vyndamax 61 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion deadline of August 26, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by January 22, 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (Immediate Use packaging, 30-count) with performance in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 24, 2025. The award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This non-set-aside, competitively awarded contract operates on a firm fixed price basis with an ultimate completion date of January 12, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The Defense Logistics Agency awarded a $55,387.88 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyndamax 61 mg capsule unit dose packs (30-count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV834Delivery Order
The Defense Logistics Agency awarded a $72,962.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Vyndamax 61 mg capsules with an ultimate completion date of February 19, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order supports the Defense Logistics Agency's medical supply chain requirements for military healthcare systems. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving multiple federal agencies. The prime contractor holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical running through December 2026, which enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, and specialty medications to support global military healthcare programs and other government medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.0k | 1/27/26 |